Gore introduces GORE TAG Conformable Thoracic Stent Graft with reduced profiles in Europe



GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

Gore has introduced reduced profiles for the most commonly used diameters of the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile allows physicians to perform TEVAR in patients with smaller vessels where access is challenging and aortic anatomy is tortuous, expanding the availability of Gore’s thoracic stent graft to a greater population of patients.

The GORE TAG Conformable Thoracic Stent Graft was modified to reduce the delivery profile of the 31, 37, and 40mm device diameters by two Fr for all lengths. The reduction in profile, through the use of a smaller diameter primary sleeve, is the only change to the device. The stent graft leverages the same predictable outcomes of the time-tested Conformable GORE TAG Device, which has established long-term freedom from reintervention (93.1%), low complication rates, with zero migrations, fractures, or compressions and a low 2.4% access site complication rate for endovascular treatment of the descending thoracic aorta. The new profiles also continue to feature the same combination of proprietary ePTFE graft material and a fully supported, nested, nitinol stent.

The new reduced profile devices continue to feature the GORE ACTIVE CONTROL System, which facilitates optimized wall apposition even in complex anatomies, such as acute aortic angles. Now, the additional reduced profiles on critical sizes needed allow the device to be introduced through a smaller sheath.

The GORE TAG Conformable Stent Graft with ACTIVE CONTROL System is part of the growing family of endovascular products that share a mission to effectively treat aortic disease, backed by Gore’s highly rated clinical support team and educational offerings. The portfolio of products includes the GORE EXCLUDER AAA Endoprosthesis for the treatment of abdominal aortic aneurysms (AAA), as well as the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System, also approved in EU.

Together, the GORE EXCLUDER device family is indicated to treat the broadest range of abdominal aortic aneurysms in patients with challenging anatomies. The GORE EXCLUDER Iliac Branch Endoprosthesis is approved in EU and is the first FDA-approved, off-the-shelf device for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms, and is indicated for use with the GORE EXCLUDER AAA Endoprosthesis. For potential additions to its branched portfolio, Gore continues to conduct studies on new and novel technologies to treat other aortic disease states.


Please enter your comment!
Please enter your name here